Nationwide expansion of prescription pharmaceutical logistics functions through ALC and FLC logistics centers
First written in FY2016. 14 of 25 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.
10 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「As part of this initiative, in January 2026, Mediceo put into operation the Group's 14th ALC, Tokyo ALC (Koto Ward, Tokyo).」
Tokyo ALC began operations in January 2026, becoming the Group's 14th ALC. The disclosure also indicates plans to address future logistics challenges and BCP requirements and to expand into a new urban logistics model. - FY2025AdvancedAnnual report
「It was completed in May 2025 as the Kobe Medical Distribution Center.」
The renovation plan for the West Japan Logistics Center resulted in completion in May 2025 as the Kobe Medical Distribution Center. - FY2024RestatedAnnual report
「In October 2023, Mediceo put into operation the Group's 13th ALC, Hanshin ALC (Nishinomiya, Hyogo). Since opening Kanagawa ALC (Totsuka Ward, Yokohama) in 2009, the Group has pursued functional enhancements and nationwide expansion, connecting manufacturers seamlessly with medical institutions and others while developing logistics centers equipped for disaster response. With the launch of Hanshin ALC, a nationwide logistics service network with consistent standards was completed.」
The disclosure again states that Hanshin ALC began operations in October 2023 and that the launch of the 13th ALC completed a nationwide logistics service network with consistent standards. - FY2024-Q2AchievedAnnual report
「Mediceo Corporation's Hanshin ALC, which had been planned as of the end of the previous consolidated fiscal year, was completed in September 2023.」
Hanshin ALC, which had previously been scheduled for completion in September 2023, was completed in September 2023, completing the project as planned. - FY2023SoftenedAnnual report
「Mediceo Corporation Hanshin ALC Nishinomiya, Hyogo Building and equipment for logistics warehouse 17,360 4,407 Internal funds September 2021 September 2023」
The scheduled completion date for Hanshin ALC changed from March 2023 to September 2023. Total capital expenditure was stated as ¥17,360 million, with ¥4,407 million already paid. - FY2023-Q3AdvancedAnnual report
「In addition, from December 2022, the Group began gradually outsourcing warehouse and delivery operations at logistics facilities, including ALCs, to Medisuket Corporation, a consolidated subsidiary, and will continue providing high-quality logistics services in compliance with GDP guidelines.」
Outsourcing of warehouse and delivery operations at logistics facilities to Medisuket began gradually in December 2022, giving concrete form to the provision of high-quality logistics services compliant with GDP. - FY2022AdvancedAnnual report
「During the consolidated fiscal year, the Group invested ¥14,969 million in capital expenditures, ¥3,180 million in software and other investments, and ¥18,150 million in total, mainly in the wholesale businesses for prescription pharmaceuticals and other products, cosmetics and daily necessities, and over-the-counter pharmaceuticals, with the aim of further strengthening and improving the efficiency of its logistics functions. In the wholesale business for prescription pharmaceuticals and other products, capital expenditures of ¥5,390 million were made, including the construction of Mediceo Corporation's Hanshin ALC.」
To expand the ALC and FLC logistics infrastructure, ¥5,390 million was invested in the construction of Hanshin ALC and related projects, with part of the total capital expenditure of ¥18,150 million allocated to strengthening logistics. Hanshin ALC was planned for completion in March 2023. - FY2021-Q2AdvancedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures. Hiroshima ALC of 株式会社エバルス (Naka-ku, Hiroshima), our wholly owned subsidiary, and Sapporo ALC of 株式会社メディセオ (Chuo-ku, Tokyo), also our wholly owned subsidiary, have been operating smoothly since May and July, respectively.」
Hiroshima ALC began operations in May and Sapporo ALC in July, moving the nationwide expansion of ALC and FLC from the completion and relocation stage to the stage of accumulating operating results. - FY2021-Q1AdvancedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures. In April 2020, 株式会社エバルス (Naka-ku, Hiroshima), our wholly owned subsidiary, completed Hiroshima ALC (Asaminami-ku, Hiroshima). In June, 株式会社メディセオ (Chuo-ku, Tokyo), also our wholly owned subsidiary, relocated Sapporo ALC (Shiroishi-ku, Sapporo) to further improve convenience for medical institutions.」
Regarding the nationwide expansion of ALC and FLC, Hiroshima ALC was completed in April 2020, and Sapporo ALC was relocated in June. - FY2020-Q3RestatedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures.」
The policy of strengthening the logistics infrastructure through the nationwide expansion of ALC and FLC continues. This filing does not describe the start of operations at new facilities or other such developments. - FY2020-Q2RestatedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures. Kanto ALC (Kazo, Saitama) at 株式会社メディセオ (Chuo-ku, Tokyo), our wholly owned subsidiary, has been operating smoothly since June 2019.」
The filing again described Kanto ALC’s operations since June 2019 and the policy of expanding ALC and FLC nationwide. It did not indicate the start of operations at any new facilities. - FY2020-Q1AdvancedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures. In June 2019, Kanto ALC (Kazo, Saitama) began operations at 株式会社メディセオ (Chuo-ku, Tokyo), our wholly owned subsidiary.」
Regarding the nationwide expansion of ALC and FLC, Kanto ALC in Kazo, Saitama, began operations in June 2019. - FY2019-Q3AdvancedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures. In November 2018, Minami-Kyushu ALC (Kirishima, Kagoshima) began operations at 株式会社アトル (Higashi-ku, Fukuoka), our wholly owned subsidiary.」
Regarding the nationwide expansion of ALC and FLC, Minami-Kyushu ALC began operations in November 2018. - FY2019-Q2AdvancedAnnual report
「Regarding the strengthening of the logistics infrastructure, while expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures, we are preparing to install ALC facilities at 2 locations, in Kazo, Saitama, and Kirishima, Kagoshima.」
Regarding the nationwide expansion of ALC and FLC, preparations are under way to install new ALC facilities at 2 locations, in Kazo, Saitama, and Kirishima, Kagoshima. - FY2019-Q1RestatedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures. We are also developing a logistics platform capable of handling all temperature ranges, including ultra-low temperatures, to ensure a stable supply of regenerative medicine products and other products requiring special management.」
The company continues to expand ALC and FLC nationwide and develop a logistics platform capable of handling all temperature ranges. - FY2018AdvancedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures. In addition, to ensure a stable supply of regenerative medicine products and other products requiring special management, we are developing a logistics platform capable of handling all temperature ranges, including ultra-low temperatures.」
In addition to the nationwide expansion of ALC and FLC, the filing newly specified the development of a logistics platform capable of handling all temperature ranges, including ultra-low temperatures, for regenerative medicine products and other products. - FY2018-Q3RestatedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures.」
The policy of strengthening the logistics infrastructure through the nationwide expansion of ALC and FLC continues. - FY2018-Q2RestatedAnnual report
「Regarding the strengthening of the logistics infrastructure, we are expanding nationwide the high-quality, high-function ALC and FLC facilities equipped with disaster countermeasures.」
The policy of strengthening the logistics infrastructure through the nationwide expansion of ALC and FLC continues, but this filing does not describe specific progress such as the start of operations at new sites. - FY2017AdvancedAnnual report
「Regarding the strengthening of the logistics infrastructure, our wholly owned operating companies are expanding ALC facilities nationwide. In July 2016, 株式会社アトル’s Fukuoka ALC (Higashi-ku, Fukuoka) began operations, followed in March 2017 by 株式会社メディセオ’s Saitama ALC (Misato, Saitama) and 株式会社エバルス’s Okayama ALC (Tsukubo-gun, Okayama).」
Following Fukuoka ALC, Saitama ALC and Okayama ALC began operations in March 2017, and the nationwide expansion of ALC progressed from the planning and construction stage to the operational stage at multiple sites. - FY2017-Q3AdvancedAnnual report
「Regarding the strengthening of the logistics infrastructure, our wholly owned operating companies are expanding ALC facilities nationwide. In July 2016, 株式会社アトル’s Fukuoka ALC (Higashi-ku, Fukuoka) began operations. In February 2017, 株式会社メディセオ’s Saitama ALC (Misato, Saitama) and 株式会社エバルス’s Okayama ALC (Tsukubo-gun, Okayama) were scheduled for completion.」
Fukuoka ALC began operations in July 2016, while Saitama ALC and Okayama ALC were scheduled for completion in February 2017. The nationwide expansion of ALC advanced to the operational and completion stage at multiple sites. - FY2017-Q2AdvancedAnnual report
「The site planned for メディセオ’s Hanshin ALC, the name of which was provisional, was acquired in June 2016, as planned at the end of the previous fiscal year.」
The planned site for Hanshin ALC was acquired in June 2016, marking further specific progress in expanding the ALC logistics network. - FY2017-Q1AdvancedAnnual report
「Including the next-generation Fukuoka ALC (Higashi-ku, Fukuoka), completed in June 2016, ALC facilities are operating at 7 locations in major metropolitan areas nationwide. Two additional facilities, in Misato, Saitama, and Tsukubo-gun, Okayama, are scheduled to begin operations by the end of the fiscal year. We are also installing FLC facilities in areas served by ALC facilities.」
The number of operating ALC sites increased from 6 to 7, with Fukuoka ALC completed in June 2016. The 2 facilities in Misato, Saitama, and Tsukubo-gun, Okayama, were scheduled to begin operations by the end of the fiscal year. - FY2016First statedAnnual report
「We are expanding nationwide the logistics functions and services provided by high-quality, high-function ALC facilities equipped with disaster countermeasures. In addition to the 6 facilities operating in major metropolitan areas, 3 new facilities are under construction in Higashi-ku, Fukuoka; Tsukubo-gun, Okayama; and Misato, Saitama. We are also installing FLC facilities in areas served by ALC facilities.」
6 ALC facilities are operational, and 3 new facilities are under construction. Installation of FLC facilities linked to ALC is also under way.